Real-time enrollment status for this kras g12c mutation clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT06720987 |
| Recruiting Status | Recruiting |
| Condition | KRAS G12C Mutation |
| Phase | Clinical Trial |
| Target Enrollment | 140 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Kumquat Biosciences Inc. |
| Last Updated on CT.gov | April 23, 2026 (Apr 23, 2026) |
As of July 13, 2026: Clinical trial NCT06720987 is currently recruiting participants. This clinical trial study for kras g12c mutation is actively seeking new participants at 11 locations across the United States. The study is sponsored by Kumquat Biosciences Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06720987 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06720987 was last updated Apr 23, 2026 (April 23, 2026). HelloStudys verifies this status automatically.